Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Leukemia

Free Subscription Articles published in Exp Hematol Retrieve available abstracts of 36 articles: HTML format

Single Articles

September 2025
1. ERNST P, Kyei P, Yokoyama A
   KMT2A-rearranged leukemia: from mechanism to drug development.
   Exp Hematol. 2025 Sep 6:105247. doi: 10.1016/j.exphem.2025.105247.
   PubMed     Abstract available
   
   
   
2. SANGHA G, Huntly BJP
   Gene regulatory complexes: their role and regulation across normal and malignant hematopoiesis.
   Exp Hematol. 2025;149:104821.
   PubMed     Abstract available
   
   
   
3. YOSHIDA S, Onozawa M, Yokoyama S, Matsukawa T, et al
   Peposertib suppresses generation of FLT3-internal tandem duplication formed by contralateral double nicks.
   Exp Hematol. 2025;149:104819.
   PubMed     Abstract available
   
   
   August 2025
4. WANG J, Xu L, Wang G, Wu W, et al
   ZC3H13 facilitates the progression of acute myeloid leukemia through m6A-FOXP1-mediated metabolic reprogramming.
   Exp Hematol. 2025 Aug 6:104862. doi: 10.1016/j.exphem.2025.104862.
   PubMed     Abstract available
   
   
   
5. SAMAREH B, Klimenkova O, Aghaallaei N, Cheng L, et al
   NAMPT-mediated deacetylation of HCLS1 protein promotes clonogenic growth of pediatric CML cells.
   Exp Hematol. 2025;148:104801.
   PubMed     Abstract available
   
   
   July 2025
6. FOSSELTEDER J, Brauchart T, Schlacher A, Sconocchia T, et al
   Engineered cytokine-expressing MSCs support ex vivo culture of human HSPCs and AML cells.
   Exp Hematol. 2025;147:104790.
   PubMed     Abstract available
   
   
   June 2025
7. ZHANG A, Qiu S
   Advances of RARalpha fusion genes in acute promyelocytic leukemia.
   Exp Hematol. 2025 Jun 7:104822. doi: 10.1016/j.exphem.2025.104822.
   PubMed     Abstract available
   
   
   May 2025
8. LU J, Xue X, Wang H, Hao Y, et al
   Notch1 activation and inhibition in T cell acute lymphoblastic leukemia subtypes.
   Exp Hematol. 2025 May 8:104771. doi: 10.1016/j.exphem.2025.104771.
   PubMed     Abstract available
   
   
   
9. CISA-WIECZOREK S, Hernandez-Alvarez MI, Parreno M, Munoz JP, et al
   D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-1.
   Exp Hematol. 2025;145:104748.
   PubMed     Abstract available
   
   
   April 2025
10. FOURNIER M, Dubuissez M, Neault M, Delisle JS, et al
    Unbiased analysis of NUP98-KDM5A-induced murine leukemia reveals phenotypic heterogeneity recapitulating human disease subtypes.
    Exp Hematol. 2025 Apr 19:104791. doi: 10.1016/j.exphem.2025.104791.
    PubMed     Abstract available
    
    
    March 2025
11. GUL AZ, Selek S, Bekiroglu S, Demirel M, et al
    Serum NMR metabolomics in distinct subtypes of hematologic malignancies.
    Exp Hematol. 2025;143:104710.
    PubMed     Abstract available
    
    
    
12. SARCHI M, Doulatov S
    Understanding Human Oncogene Function and Cooperativity in Myeloid Malignancy Using iPSCs.
    Exp Hematol. 2025;143:104697.
    PubMed     Abstract available
    
    
    
13. GUIRGUIS AA
    RNA methylation: where to from here for hematologic malignancies?
    Exp Hematol. 2025;143:104694.
    PubMed     Abstract available
    
    
    February 2025
14. TACHIBANA T, Izumi A, Arai S, Takeda T, et al
    Preconditioning intervention before allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.
    Exp Hematol. 2025 Feb 12:104746. doi: 10.1016/j.exphem.2025.104746.
    PubMed     Abstract available
    
    
    
15. DE GROOT AP, Nguyen H, Pouw JS, Weersing E, et al
    CBX7 inhibitors affect H3K9 methyltransferase-regulated gene repression in leukemic cells.
    Exp Hematol. 2025;142:104691.
    PubMed     Abstract available
    
    
    January 2025
16. AMOR AR, Enlund S, Sinha I, Jiang Q, et al
    A Distinct Alternative mRNA Splicing Profile Identifies the Oncogenic CD44 Transcript Variant 3 in KMT2A-Rearranged Pediatric T-cell Acute Lymphoblastic Leukemia Cells.
    Exp Hematol. 2025 Jan 8:104712. doi: 10.1016/j.exphem.2025.104712.
    PubMed     Abstract available
    
    
    November 2024
17. QU Y, Shourabizadeh H, Subramanian A, Aleman DM, et al
    DIFFERENTIAL IMPACT OF CD34+ CELL DOSE FOR DIFFERENT AGE GROUPS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR ACUTE LEUKEMIA: A MACHINE LEARNING-BASED DISCOVERY.
    Exp Hematol. 2024 Nov 22:104684. doi: 10.1016/j.exphem.2024.104684.
    PubMed     Abstract available
    
    
    October 2024
18. KOHNKE T, Feng Y, Majeti R
    A New Era of Functional Experimentation in Human Hematopoiesis and Leukemia Research.
    Exp Hematol. 2024 Oct 1:104652. doi: 10.1016/j.exphem.2024.104652.
    PubMed     Abstract available
    
    
    September 2024
19. KHAMARI R, Degand C, Fovez Q, Trinh A, et al
    Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors.
    Exp Hematol. 2024;137:104253.
    PubMed     Abstract available
    
    
    August 2024
20. CAMIOLO G, Mullen CG, Ottersbach K
    Mechanistic insights into the developmental origin of pediatric hematologic disorders.
    Exp Hematol. 2024;136:104583.
    PubMed     Abstract available
    
    
    June 2024
21. ONG KOK, Mok MMH, Niibori-Nambu A, Du L, et al
    Activation of NOTCH signaling impedes cell proliferation and survival in acute megakaryoblastic leukemia.
    Exp Hematol. 2024 Jun 12:104255. doi: 10.1016/j.exphem.2024.104255.
    PubMed     Abstract available
    
    
    
22. STRAUBE J, Janardhanan Y, Haldar R, Bywater MJ, et al
    Immune control in acute myeloid leukemia.
    Exp Hematol. 2024 Jun 12:104256. doi: 10.1016/j.exphem.2024.104256.
    PubMed     Abstract available
    
    
    
23. ROGERS JH, Rosen A, Reyes JM, Ketkar S, et al
    Dose-dependent effects of Dnmt3a in an inducible murine model of Kras(G12D)-driven leukemia.
    Exp Hematol. 2024 Jun 2:104248. doi: 10.1016/j.exphem.2024.104248.
    PubMed     Abstract available
    
    
    
24. XU JJ, Viny AD
    Chromatin organization in myelodysplastic syndrome.
    Exp Hematol. 2024;134:104216.
    PubMed     Abstract available
    
    
    May 2024
25. ZHOU Q, Li Z, Xi Y
    EV-mediated intercellular communication in acute myeloid leukemia: Transport of genetic materials in the bone marrow microenvironment.
    Exp Hematol. 2024;133:104175.
    PubMed     Abstract available
    
    
    March 2024
26. PANTING RG, Kotecha RS, Cheung LC
    The critical role of the bone marrow stromal microenvironment for development of drug screening platforms in leukemia.
    Exp Hematol. 2024 Mar 27:104212. doi: 10.1016/j.exphem.2024.104212.
    PubMed     Abstract available
    
    
    
27. GOSWAMI M, Bose PD
    Gut Microbial Dysbiosis in the Pathogenesis of Leukemia: An Immune-based Perspective.
    Exp Hematol. 2024 Mar 23:104211. doi: 10.1016/j.exphem.2024.104211.
    PubMed     Abstract available
    
    
    
28. LIU Q, Zhai Y, Hui Y, Chen J, et al
    Identification of Red blood cell distribution width as a prognostic factor in acute myeloid leukemia.
    Exp Hematol. 2024 Mar 18:104206. doi: 10.1016/j.exphem.2024.104206.
    PubMed     Abstract available
    
    
    February 2024
29. TANAKA T, Kudo K, Kanezaki R, Yuzawa K, et al
    Anti-leukemic effect of azacitidine, a DNA methyltransferase inhibitor, on cell lines of myeloid leukemia associated with Down syndrome.
    Exp Hematol. 2024 Feb 9:104179. doi: 10.1016/j.exphem.2024.104179.
    PubMed     Abstract available
    
    
    
30. RANDALL J, Evans K, Watts B, Kosasih HJ, et al
    IN VIVO ACTIVITY OF THE SECOND-GENERATION PROTEASOME INHIBITOR IXAZOMIB AGAINST PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA XENOGRAFTS.
    Exp Hematol. 2024 Feb 4:104176. doi: 10.1016/j.exphem.2024.104176.
    PubMed     Abstract available
    
    
    
31. MERZ AMA, Platzbecker U
    Beyond the horizon: emerging therapeutic approaches in myelodysplastic neoplasms.
    Exp Hematol. 2024;130:104130.
    PubMed     Abstract available
    
    
    December 2023
32. ALQAZZAZ MA, Luciani GM, Vu V, Machado RM, et al
    Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations.
    Exp Hematol. 2023 Dec 8:S0301-472X(23)01773-3. doi: 10.1016/j.exphem.2023.
    PubMed     Abstract available
    
    
    
33. BUROCZIOVA M, Grusanovic S, Vanickova K, Kosanovic S, et al
    Chronic inflammation promotes cancer progression as a second hit.
    Exp Hematol. 2023;128:30-37.
    PubMed     Abstract available
    
    
    October 2023
34. XIE Y, Tan L, Wu K, Li D, et al
    MiR-455-3p mediates PPARalpha through UBN2 to promote apoptosis and autophagy in acute myeloid leukemia cells.
    Exp Hematol. 2023 Oct 5:S0301-472X(23)01734-4. doi: 10.1016/j.exphem.2023.
    PubMed     Abstract available
    
    
    September 2023
35. GUARNERA L, Santinelli E, Galossi E, Cristiano A, et al
    Microenvironment in Acute Myeloid Leukemia: focus on senescence mechanisms, therapeutic interactions and future directions.
    Exp Hematol. 2023 Sep 21:S0301-472X(23)01705.
    PubMed     Abstract available
    
    
    
36. HAN L, Wu J, Lyu X, Yu J, et al
    Genetic Mutation Signature for Relapse Prediction in Normal Karyotype Acute Myeloid Leukemia.
    Exp Hematol. 2023 Sep 20:S0301-472X(23)01706.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.